Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Organic Compound

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385612

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1385612

Quinine Market - Global Quinine Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030

PUBLISHED:
PAGES: 236 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global quinine market, driven by increasing health consciousness and rising awareness, is expected to witness substantial growth in the coming years. According to a recent report by Fairfield Market Research, the market was valued at approximately US$2.1 billion in 2022 and is projected to reach US$3.2 billion by 2030, with a CAGR of 6.5% between 2023 and 2030.

Market Drivers

Several key factors are contributing to the growth of the quinine market:

Increasing Demand for Tonic Water: Tonic water, containing quinine, is gaining popularity as a healthful beverage globally. With its exceptional therapeutic properties, including its use in malaria treatment and relieving leg cramps, quinine's market is expanding due to the rising global demand for tonic water.

Rising Cases of Malaria: The world has witnessed a surge in malaria cases, with over 14 million new cases reported in 2020, the highest levels since 2012. Quinine, an effective treatment for malaria, is expected to see increased demand due to the growing number of malaria patients.

Rising Alcoholic Beverage Consumption: Quinine is a key ingredient in some bitter alcoholic beverages like gin and tonic, which have gained popularity worldwide. This trend, along with the increasing popularity of alcoholic beverages like beer, wine, and spirits, is driving up the sales of quinine.

Market Challenges

Despite the promising growth, some challenges are impacting the quinine market:

Low Awareness Among Consumers: Quinine is often marketed as a mixer for alcoholic beverages, limiting its recognition as a versatile product with various uses.

Potential Health Issues: Some health complications, such as fever, headaches, and vision impairments, have been associated with quinine consumption, potentially affecting market growth.

Key Trends and Opportunities

The quinine market offers several opportunities for growth:

Product Innovations: Ongoing product innovation, including the use of quinine from natural sources and natural sweeteners, is expected to drive market expansion. Manufacturers are investing in research and development to create new flavors that cater to different consumer preferences.

Rising Consumer Spending Power: The increase in disposable income due to industrialization and economic progress is contributing to the growth of the quinine market. Urbanization and the influence of social media are also driving alcohol consumption and the demand for quinine.

Expanding Cocktail Culture: Tonic water is commonly used as a mixer in cocktails and mocktails, especially among gin and whisky drinkers. The growing cocktail culture is expected to open up new opportunities for the quinine sector.

Regional Outlook

North America: The North American region, including the U.S. and Canada, is expected to dominate the quinine market due to a high frequency of malaria and other mosquito-borne diseases. Additionally, the consumption of spirits like gin and tonic is on the rise.

Asia Pacific: The Asia Pacific region is projected to experience significant growth, driven by increased product approvals, rising awareness of malaria, and the consumption of spirits. India, China, and Indonesia are among the key markets driving demand.

Competitive Landscape

The quinine market is concentrated, with several major players driving innovation and expanding their distribution networks. Market consolidation is anticipated in the coming years. Some of the leading companies in the global quinine space include:

  • Aecochem Corp
  • Haihang Industry Co. Ltd.
  • Actavis
  • Shreeji Pharma International
  • Wockhardt
  • Vital Labs
  • Trademax Pharmaceuticals & Chemicals
  • Van Wankum Ingredients
  • Hangzhou Dayang Co. Ltd.
  • IS Chemical Technology Ltd.
  • Leocorno Enterprises
  • Bickford & Sons
  • Fever-Tree
  • Schweppes
  • Chempro Pharma Private Limited

Global Quinine Market is Segmented as Below:

By Type:

  • 200 mg
  • 300 mg
  • Other

By Application:

  • Problematic Leg Cramps
  • Malaria
  • Other

By Administration:

  • Oral Administration
  • Intramuscular Administration
  • Intravenous Administration
  • Others

By End User:

  • Hospitals
  • Clinics
  • Others

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Quinine Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Quinine Market Outlook, 2018 - 2030

  • 3.1. Global Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. 200 mg
      • 3.1.1.2. 300 mg
      • 3.1.1.3. Other
  • 3.2. Global Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Problematic Leg Cramps
      • 3.2.1.2. Malaria
      • 3.2.1.3. Other
  • 3.3. Global Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oral Administration
      • 3.3.1.2. Intramuscular Administration
      • 3.3.1.3. Intravenous Administration
      • 3.3.1.4. Others
  • 3.4. Global Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights Snacks
      • 3.4.1.1. Hospitals
      • 3.4.1.2. Clinics
      • 3.4.1.3. Others
  • 3.5. Global Quinine Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Quinine Market Outlook, 2018 - 2030

  • 4.1. North America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. 200 mg
      • 4.1.1.2. 300 mg
      • 4.1.1.3. Other
  • 4.2. North America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Problematic Leg Cramps
      • 4.2.1.2. Malaria
      • 4.2.1.3. Other
  • 4.3. North America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oral Administration
      • 4.3.1.2. Intramuscular Administration
      • 4.3.1.3. Intravenous Administration
      • 4.3.1.4. Others
  • 4.4. North America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Clinics
      • 4.4.1.3. Others
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis
  • 4.5. North America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.2. U.S. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.3. U.S. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.4. U.S. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 4.5.1.5. Canada Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 4.5.1.6. Canada Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 4.5.1.7. Canada Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 4.5.1.8. Canada Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Quinine Market Outlook, 2018 - 2030

  • 5.1. Europe Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. 200 mg
      • 5.1.1.2. 300 mg
      • 5.1.1.3. Other
  • 5.2. Europe Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Problematic Leg Cramps
      • 5.2.1.2. Malaria
      • 5.2.1.3. Other
  • 5.3. Europe Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oral Administration
      • 5.3.1.2. Intramuscular Administration
      • 5.3.1.3. Intravenous Administration
      • 5.3.1.4. Others
  • 5.4. Europe Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Clinics
      • 5.4.1.3. Others
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis
  • 5.5. Europe Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.2. Germany Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.3. Germany Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.4. Germany Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.5. U.K. Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.6. U.K. Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.7. U.K. Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.8. U.K. Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.9. France Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.10. France Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.11. France Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.12. France Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.13. Italy Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.14. Italy Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.15. Italy Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.16. Italy Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.17. Turkey Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.18. Turkey Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.19. Turkey Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.20. Turkey Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.21. Russia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.22. Russia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.23. Russia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.24. Russia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 5.5.1.25. Rest of Europe Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 5.5.1.26. Rest of Europe Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 5.5.1.27. Rest of Europe Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 5.5.1.28. Rest of Europe Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Quinine Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. 200 mg
      • 6.1.1.2. 300 mg
      • 6.1.1.3. Other
  • 6.2. Asia Pacific Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Problematic Leg Cramps
      • 6.2.1.2. Malaria
      • 6.2.1.3. Other
  • 6.3. Asia Pacific Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oral Administration
      • 6.3.1.2. Intramuscular Administration
      • 6.3.1.3. Intravenous Administration
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Clinics
      • 6.4.1.3. Others
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis
  • 6.5. Asia Pacific Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.2. China Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.3. China Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.4. China Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.5. Japan Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.6. Japan Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.7. Japan Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.8. Japan Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.9. South Korea Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.10. South Korea Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.11. South Korea Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.12. South Korea Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.13. India Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.14. India Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.15. India Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.16. India Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.17. Southeast Asia Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.18. Southeast Asia Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.19. Southeast Asia Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.20. Southeast Asia Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 6.5.1.21. Rest of Asia Pacific Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 6.5.1.22. Rest of Asia Pacific Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 6.5.1.23. Rest of Asia Pacific Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 6.5.1.24. Rest of Asia Pacific Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Quinine Market Outlook, 2018 - 2030

  • 7.1. Latin America Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. 200 mg
      • 7.1.1.2. 300 mg
      • 7.1.1.3. Other
  • 7.2. Latin America Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Problematic Leg Cramps
      • 7.2.1.2. Malaria
      • 7.2.1.3. Other
  • 7.3. Latin America Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oral Administration
      • 7.3.1.2. Intramuscular Administration
      • 7.3.1.3. Intravenous Administration
      • 7.3.1.4. Others
  • 7.4. Latin America Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Clinics
      • 7.4.1.3. Others
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis
  • 7.5. Latin America Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.2. Brazil Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.3. Brazil Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.4. Brazil Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.5. Mexico Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.6. Mexico Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.7. Mexico Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.8. Mexico Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.9. Argentina Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.10. Argentina Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.11. Argentina Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.12. Argentina Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 7.5.1.13. Rest of Latin America Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 7.5.1.14. Rest of Latin America Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 7.5.1.15. Rest of Latin America Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 7.5.1.16. Rest of Latin America Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Quinine Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Quinine Market Outlook, by Type, Value (US$ Mn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. 200 mg
      • 8.1.1.2. 300 mg
      • 8.1.1.3. Other
  • 8.2. Middle East & Africa Quinine Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Problematic Leg Cramps
      • 8.2.1.2. Malaria
      • 8.2.1.3. Other
  • 8.3. Middle East & Africa Quinine Market Outlook, by Administration, Value (US$ Mn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oral Administration
      • 8.3.1.2. Intramuscular Administration
      • 8.3.1.3. Intravenous Administration
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Quinine Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Clinics
      • 8.4.1.3. Others
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Middle East & Africa Quinine Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.2. GCC Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.3. GCC Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.4. GCC Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.5. South Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.6. South Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.7. South Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.8. South Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.9. Egypt Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.10. Egypt Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.11. Egypt Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.12. Egypt Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.13. Nigeria Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.14. Nigeria Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.15. Nigeria Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.16. Nigeria Quinine Market by End User, Value (US$ Mn), 2018 - 2030
      • 8.5.1.17. Rest of Middle East & Africa Quinine Market by Type, Value (US$ Mn), 2018 - 2030
      • 8.5.1.18. Rest of Middle East & Africa Quinine Market by Application, Value (US$ Mn), 2018 - 2030
      • 8.5.1.19. Rest of Middle East & Africa Quinine Market by Administration, Value (US$ Mn), 2018 - 2030
      • 8.5.1.20. Rest of Middle East & Africa Quinine Market by End User, Value (US$ Mn), 2018 - 2030
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs Application Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Aecochem Corp
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Haihang Industry Co. Ltd.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Actavis
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Shreeji Pharma International
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Wockhardt
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Vital Labs
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Trademax Pharmaceuticals & Chemicals
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Van Wankum Ingredients
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Hangzhou Dayang Co. Ltd.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Business Strategies and Development
    • 9.4.10. IS Chemical Technology Ltd.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Leocorno Enterprises
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Bickford & Sons
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Fever-Tree
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Schweppes
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Chempro Pharma Private Limited
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!